Emerging IgA Nephropathy Therapies: Key Companies Shaping the Evolving Treatment Landscape
IgA Nephropathy (IgAN), also known as Berger's disease, is a chronic autoimmune kidney disorder caused by the deposition of immunoglobulin A in the glomeruli, leading to inflammation and progressive renal damage. Over the past few years, the therapeutic landscape for this condition has evolved rapidly, with several biopharmaceutical companies advancing novel mechanisms that go beyond...